Gilles Carmel

5.7k total citations · 2 hit papers
21 papers, 2.5k citations indexed

About

Gilles Carmel is a scholar working on Molecular Biology, Hematology and Materials Chemistry. According to data from OpenAlex, Gilles Carmel has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Hematology and 5 papers in Materials Chemistry. Recurrent topics in Gilles Carmel's work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Gilles Carmel is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Gilles Carmel collaborates with scholars based in United States, Canada and Japan. Gilles Carmel's co-authors include Jeff Kuret, Lester I. Binder, Edward M. Mager, Brian E. Cathers, Antonia Lopez‐Girona, Emily Rychak, Hiroshi Handa, Takumi Ito, Xiaodong Cheng and Peter Schäfer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Gilles Carmel

21 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

2012 606 citations Antonia Lopez‐Girona, Derek Mendy et al. Leukemia profile →
Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs

2014 371 citations Philip P. Chamberlain, Antonia Lopez‐Girona et al. Nature Structural & Molecular Biology profile →

Peers

Countries citing papers authored by Gilles Carmel

Since Specialization

Citations

This map shows the geographic impact of Gilles Carmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Carmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Carmel more than expected).

Fields of papers citing papers by Gilles Carmel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Carmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Carmel. The network helps show where Gilles Carmel may publish in the future.

Co-authorship network of co-authors of Gilles Carmel

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Carmel. A scholar is included among the top collaborators of Gilles Carmel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Carmel. Gilles Carmel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos 2017 ·Journal of Medicinal Chemistry ·Mary E. Matyskiela, Weihong Zhang, Hon‐Wah Man, George W. Muller, Godrej Khambatta, (unknown), Matthew Hickman, Laurie A. LeBrun, Barbra Pagarigan, Gilles Carmel, Chin-Chun Lu, Gang Lu, Mariko Riley, Yoshitaka Satoh, Peter Schäfer, Thomas O. Daniel, James Carmichael, Brian E. Cathers, Philip P. Chamberlain	203
2	Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs breakdown → 2014 ·Nature Structural & Molecular Biology ·Philip P. Chamberlain, Antonia Lopez‐Girona, Karen Miller, Gilles Carmel, Barbra Pagarigan, B. Chie-Leon, Emily Rychak, Laura G. Corral, Yan Ren, Maria Wang, Mariko Riley, S.L. Delker, Takumi Ito, Hideki Ando, Tomoyuki Mori, Yoshinori Hirano, Hiroshi Handa, Toshio Hakoshima, Thomas O. Daniel, Brian E. Cathers	371
3	Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity 2013 ·British Journal of Haematology ·Anita K. Gandhi, Derek Mendy, Michelle F. Waldman, Gengxin Chen, Emily Rychak, Karen Miller, Svetlana Gaidarova, Yan Ren, Maria Wang, Michael A. Breider, Gilles Carmel, (unknown), Pilgrim J. Jackson, Mahan Abbasian, Brian E. Cathers, Peter Schäfer, Tom Daniel, Antonia Lopez‐Girona, Anjan Thakurta, Rajesh Chopra	71
4	Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide breakdown → 2012 ·Leukemia ·Antonia Lopez‐Girona, Derek Mendy, Takumi Ito, Karl N. Miller, Anita K. Gandhi, Jian Kang, Satoki Karasawa, Gilles Carmel, Pilgrim J. Jackson, Mahan Abbasian, Ali Mahmoudi, Brian E. Cathers, Emily Rychak, Svetlana Gaidarova, (unknown), Peter Schäfer, Hiroshi Handa, Tom Daniel, Jilly F. Evans, Rajesh Chopra	606
5	Direct Binding with Cereblon Mediates the Antiproliferative and Immunomodulatory Action of Lenalidomide and Pomalidomide 2011 ·Blood ·Antonia Lopez‐Girona, Derek Mendy, Karen Miller, Anita K. Gandhi, Jian Kang, Gilles Carmel, Mahan Abbasian, (unknown), Pilgrim J. Jackson, Brian E. Cathers, Emily Rychak, Normand Richard, Helen Brady, Peter Schäfer, Jilly F. Evans, Tom Daniel, Rajesh Chopra	4
6	Identification and Characterization of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase 2004 ·Antimicrobial Agents and Chemotherapy ·Losee L. Ling, Jun Xian, Syed Muhammad Adnan Ali, Bolin Geng, Jun Fan, Debra M. Mills, Anthony C. Arvanites, Hernán A. Orgueira, Mark A. Ashwell, Gilles Carmel, Yibin Xiang, Donald T. Moir	58
7	Helicobacter pylori 3-deoxy-D-manno-octulosonate-8-phosphate (KDO-8-P) synthase is a zinc-metalloenzyme 2002 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Daniel J. Krosky, Richard A. Alm, Mikael Berg, Gilles Carmel, Peter J. Tummino, Bo Xu, Wei Yang	22
8	Structure of the Unliganded cAMP-Dependent Protein Kinase Catalytic Subunit from Saccharomyces cerevisiae 2001 ·Archives of Biochemistry and Biophysics ·Neda Mashhoon, Gilles Carmel, J. W. Pflugrath, Jeff Kuret	12
9	Helicobacter pyloriPhysiology Predicted from Genomic Comparison of Two Strains 1999 ·Microbiology and Molecular Biology Reviews ·P. Doig, B L de Jonge, Richard A. Alm, Eric D. Brown, Maria Uria-Nickelsen, Brian Noonan, Scott D. Mills, Peter J. Tummino, Gilles Carmel, Braydon C. Guild, Donald T. Moir, Gerald F. Vovis, T J Trust	147
10	The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology 1996 ·Journal of Biological Chemistry ·Gilles Carmel, Edward M. Mager, Lester I. Binder, Jeff Kuret	361
11	Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors. 1996 ·Proceedings of the National Academy of Sciences ·Rui-Ming Xu, Gilles Carmel, Jeff Kuret, Xiaodong Cheng	37
12	Crystal structure of casein kinase-1, a phosphate-directed protein kinase. 1995 ·The EMBO Journal ·Rui-Ming Xu, Gilles Carmel, R.M. Sweet, Jeff Kuret, Xiaodong Cheng	161
13	Budding and fission yeast casein kinase I isoforms have dual-specificity protein kinase activity. 1994 ·Molecular Biology of the Cell ·Merl F. Hoekstra, Namrita Dhillon, Gilles Carmel, Anthony J. DeMaggio, Richard Lindberg, Tony Hunter, Jeff Kuret	58
14	Expression, purification, crystallization, and preliminary x-ray analysis of casein kinase-1 from Schizosaccharomyces pombe. 1994 ·Journal of Biological Chemistry ·Gilles Carmel, (unknown), Xiaodong Cheng, Scott D. Patterson, Urooj A. Mirza, Brian T. Chait, Jeff Kuret	56
15	Cytoplasmic forms of fission yeast casein kinase-1 associate primarily with the particulate fraction of the cell. 1994 ·Journal of Biological Chemistry ·(unknown), Aleš Vančura, (unknown), Gilles Carmel, Jeff Kuret	31
16	A solid-phase screen for protein kinase substrate selectivity 1992 ·Analytical Biochemistry ·Gilles Carmel, Jeff Kuret	5
17	Internal deletions in the FhuA receptor of Escherichia coli K-12 define domains of ligand interactions 1991 ·Journal of Bacteriology ·Gilles Carmel, James W. Coulton	37
18	Insertion mutagenesis of the gene encoding the ferrichrome-iron receptor of Escherichia coli K-12 1990 ·Journal of Bacteriology ·Gilles Carmel, (unknown), D Henning, James W. Coulton	25
19	Protein fusions of beta-galactosidase to the ferrichrome-iron receptor of Escherichia coli K-12 1986 ·Journal of Bacteriology ·James W. Coulton, P. Mason, David R. Cameron, Gilles Carmel, (unknown), Harold Rode	98
20	Composition and physical properties of lipids from plasma membranes of dog kidney 1985 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Gilles Carmel, (unknown), S Carrière, Christian Le Grimellec	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact